Clarkston Capital Partners, LLC Trevena Inc Transaction History

Clarkston Capital Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$1.77 - $2.93 $35,400 - $58,600	-20,000 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$0.48 - $1.75 $3,840 - $14,000	-8,000 Reduced 28.57%	20,000 $30,000
Q4 2018 Jan 17, 2019	BUY	$0.39 - $3.47 $10,920 - $97,160	28,000 New	28,000 $12,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $320M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Clarkston Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Clarkston Capital Partners, LLC with notifications on news.